Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial.
Nacro B, Zoure E, Hien H, Tamboura H, Rouet F, Ouiminga A, Drabo A, Yameogo S, Hien A, Peyriere H, Mathieu O, Hirt D, Treluyer JM, Nicolas J, Foulongne V, Segondy M, van de Perre P, Diagbouga S, Msellati P.
Nacro B, et al. Among authors: van de perre p.
Bull World Health Organ. 2011 Jun 1;89(6):451-8. doi: 10.2471/BLT.10.081646. Epub 2011 Apr 6.
Bull World Health Organ. 2011.
PMID: 21673861
Free PMC article.
Clinical Trial.